Authorised by Swissmedic.
Cannabinoid APIs, purified extracts and advanced formulation solutions engineered in Switzerland for regulated industries and pharmaceutical partners worldwide.
High-purity THC and CBD APIs, including minor cannabinoids on request—built for regulated development.
Full-spectrum extracts and standardized cannabinoid fractions with controlled concentration profiles.
Stability, solubility, and dosage-consistency support to help translate actives into usable formats.
Potency testing, impurity profiling, batch validation, and stability studies with documentation support.
ProSanitate is a Switzerland-based pharmaceutical platform dedicated to the development, refinement, and supply of cannabinoid-based active substances and intermediate products for regulated pharmaceutical industries.
Operating within the Swiss regulatory and scientific ecosystem, we combine pharmaceutical-grade manufacturing discipline with advanced cannabinoid innovation across the full value chain—from extraction and purification to formulation support and analytical validation.
ProSanitate is a Swiss-based producer and supplier of regulated cannabis products, operating within a fully compliant, traceable, and industrial-grade framework.
Our product portfolio is designed to meet the needs of licensed operators, manufacturers, and institutional partners seeking reliable quality, regulatory security, and long-term supply.
All products are developed under controlled conditions and aligned with Swissmedic standards, ensuring consistency, transparency, and full batch traceability from origin to delivery.
Our scientific platform integrates advanced extraction technologies, pharmaceutical purification workflows, and validated analytical systems operated within the Swiss regulatory framework—so every batch is supported by structured technical data packages suitable for regulatory environments.
ProSanitate operates within the Swiss regulatory framework governing the production and supply of cannabis products.
Our facilities and processes are subject to regulatory oversight, inspections, and authorization by Swiss authorities, including Swissmedic, in accordance with applicable laws and standards.
This regulatory foundation ensures full traceability, quality control, and compliance across all stages of production, from cultivation to processing and transformation.
Operating within the Swiss regulatory and scientific ecosystem, we combine pharmaceutical-grade manufacturing discipline with advanced cannabinoid innovation across the full value chain—from extraction and purification to formulation support and analytical validation.
From API development to purified extracts, formulation support, and analytical verification, ProSanitate enables regulated partners to move from R&D to compliant supply with confidence.
THC APIs, CBD APIs, and minor cannabinoids on request—delivered with controlled purity specifications and GMP-ready documentation.
Full-spectrum extracts, purified cannabinoid fractions, and standardized concentration profiles supported by analytical verification.
Solubility optimization, stability engineering, dosage consistency, and delivery format development for regulated pipelines.
We collaborate with universities and medical experts to study new cannabinoid applications and accelerate innovation responsibly.
Applied research focused on process optimization, yield efficiency, molecular stability, and scalable industrial production.
Potency testing, impurity profiling, batch validation, and stability studies—supporting audits, submissions, and regulated supply decisions.
We offer a regulated portfolio spanning flowers, seeds, and extractions of both CBD and THC—supported by testing and documentation aligned to Swiss regulatory expectations for applicable orders.
Every operational layer is designed around traceability, reproducibility, and documentation discipline.
Clear specifications, clear documentation, and clear communication—so quality and compliance expectations are aligned from day one.
GMP-aligned workflows, batch traceability, and audit readiness embedded into the production and quality process.
Potency testing, impurity profiling, and stability studies support confident development decisions and regulated submissions.
Operating within the Swiss regulatory and scientific ecosystem, combining pharmaceutical-grade discipline with cannabinoid innovation.
Contact Pro Sanite now
Quality governance is embedded at every operational layer and aligned with Swiss pharmaceutical regulatory standards.
+44 7908021868
10.00am - 6.00pm
Institutional-grade quality, documentation discipline, and consistent supply.
The documentation quality and batch consistency made internal review straightforward and reduced back-and-forth during QA